Development

A neoantigen vaccine to prevent colon cancer clears early trials

development2026-01-24

Claim

A proof-of-concept neoantigen vaccine to prevent colon cancer showed strong immune responses and safety in early human trials.

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Evidence for
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.